(509e) Macromolecular Engineering in Silicone Hydrogel Contact Lenses for the Controlled Release of Multiple Small Molecules | AIChE

(509e) Macromolecular Engineering in Silicone Hydrogel Contact Lenses for the Controlled Release of Multiple Small Molecules

Authors 

DiPasquale, S. A. - Presenter, Biomimetic & Biohybrid Materials, Biomedical Devices, & Drug Delivery Laboratories Department of Biomedical Engineering, Rowan University
Byrne, M., Rowan University
Uricoli, B., Rowan University
DiCerbo, M. C., Biomimetic & Biohybrid Materials, Biomedical Devices, & Drug Delivery Laboratories Department of Biomedical Engineering, Rowan University
In this work we demonstrate for the first time extended and controlled release of multiple small molecules for post-cataract treatment from silicone hydrogel contact lenses for the duration of wear. There is currently an unmet need for more a convenient and efficient treatment of ocular ailments. The current state of the art for ocular drug delivery, topical eye drops and ointments, are inefficient and inefficacious, suffering from a low bioavailability as well as patient compliance issues. In this work, we have designed continuous wear silicone hydrogel contact lenses that can release non-steroidal anti-inflammatory drugs (NSAIDS) and steroidal anti-inflammatory drugs (SAIDS). Our engineered biomimetic drug-delivering silicone hydrogel contact lenses exploit a polymer engineering technique pioneered by our laboratory known as macromolecular memory to release multiple therapeutics at a controlled and extended rate. Macromolecular memory involves the addition of functional monomers to the pre-polymerization hydrogel formulation that bind to the template drug via non-covalent interactions. Functional monomer-template complexes are integrated into the polymer macrostructure during polymerization, resulting is a polymer with memory sites that allow a controlled affinity for the template drug based on size as well as chemistry.

Contact lenses were prepared using a mixture of silicone macromer methacryloxypropyl terminated polydimethylsiloxane (DMS-R11), methacryloxypropyl-tris-(trimethylsiloxy) silane (TRIS), and dimethyl acrylamide (DMA). Crosslinking monomers ethylene glycol dimethacrylate (EGDMA) and polyethylene glycol 200 dimethacrylate (PEG200DMA) as well as functional monomers diethylaminoethyl methacrylate (DEAEM), and diallyldimethyl ammonium chloride (DADMAC). Ethanol was included in the pre-polymer formulation to help dissolve template molecules and create a homogeneous lens solution. Heavily prescribed post-cataract therapeutics including dexamethasone sodium phosphate (DMSP), diclofenac sodium (DS), and bromfenac sodium (BS) were selected as template molecules. Lenses were synthesized using UV photopolymerization with a free radical initiator. Release experiments were conducted using a poly-dimethylsiloxane microfluidic device possessing an inner chamber with an inlet and an outlet, and a radius of curvature of 9.00 mm ± 0.1. To simulate physiological tear flow, release media was injected into the chamber at 3 μL/min, while an outlet line removed fluid from the chamber. Lens optical clarity was analyzed by measuring percent light transmittance using a UV/Vis spectrophotometer.

Contact lenses synthesized in presence of template molecules showed higher binding affinity and loading capacity than lenses synthesized without template. Further investigation of release studies suggested that macromolecular memory sites extended the release of both template molecules. Lenses with memory were able to extend therapeutic release of DS and DMSP up to seven days while control lenses with no memory released 90% of their payload by two days. In this study, additional therapeutic was applied to the surface of lenses to allow for a release of 40% of the total payload within the first day before slowing to a rate of 5.4 ± 0.6 μg/day for DMSP and 8.6 ± 1.0 μg/day for DS. By changing the functional monomer to template drug (M/T) ratio, lenses could be tailored to release multiple molecules at controlled rates. The NSAID bromfenac sodium was released from two different engineered lenses. By increasing the M/T ratio from 3 to 25, therapeutic delivery duration increased from 14 days to 36 days. Synthesized lenses met the commercial standards for elastic modulus (~3.5 MPa) as well as optical clarity (>90% optical transmittance). Silicone hydrogels are biphasic, and thus contain hydrophobic groups on the surface. Lens surfaces were treated with a plasma coater in order to create a purely hydrophilic surface. In order to determine hydrophilicity, contact angle between water and the surface of the lens was measured and found to be ~16°, which meets the commercial standard of <49°

Results indicated that macromolecular memory can be used to create custom hydrogels that release at specific sustained rates. This is the first time significant control over release of multiple molecules with diverse functionality has been demonstrated from a single lens for the duration of wear. This technology has significant potential as a more efficacious and effective method of treating ocular ailments.